Novavax (NVAX) - Stock price history

Stock price history of Novavax from 1995 to 2026

Annual Stock Price Performance

Year	Performance
2026	39.14%
2025	-21.59%
2024	59.84%
2023	-50.97%
2022	-92.81%
2021	26.63%
2020	2,383.52%
2019	-89.90%
2018	41.54%
2017	-2.36%
2016	-84.01%
2015	45.66%
2014	13.82%
2013	159.90%
2012	36.96%
2011	-50.97%
2010	-13.52%
2009	31.68%
2008	-42.02%
2007	-13.95%
2006	5.67%
2005	18.83%
2004	-45.76%
2003	114.29%
2002	-80.91%
2001	67.66%
2000	47.83%
1999	181.25%
1998	-61.73%
1997	48.15%
1996	-14.06%
1995	-6.25%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Novartis NVS	120,92 €	0.06%	🇨🇭 Switzerland
Pfizer PFE	23,94 €	-0.33%	🇺🇸 USA
AstraZeneca AZN	142,01 €	0.64%	🇬🇧 UK
GSK plc GSK	43,84 €	0.56%	🇬🇧 UK
Sarepta Therapeutics SRPT	17,23 €	-4.63%	🇺🇸 USA
Celldex Therapeutics CLDX	33,75 €	0.52%	🇺🇸 USA
Agenus AGEN	6,29 €	0.70%	🇺🇸 USA
NanoViricides NNVC	1,05 €	14.29%	🇺🇸 USA
BioCryst Pharmaceuticals BCRX	7,35 €	3.31%	🇺🇸 USA
Emergent BioSolutions EBS	5,88 €	6.13%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Novavax (NVAX)